NCT00552058 2018-08-09
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
UCB Pharma
Phase 3 Completed
Clinical Trials
5 trialsNCT00333788 2018-08-07
Welcome2
UCB Pharma
Phase 3 Completed
NCT00354367 2012-05-28
Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas
UCB Pharma
Phase 3 Withdrawn
NCT00358683 2012-05-28
A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease
UCB Pharma
Phase 3 Withdrawn
NCT00297648 2011-08-31
MUSIC
UCB Pharma
Phase 3 Completed